1. Home
  2. TUYA vs SLDB Comparison

TUYA vs SLDB Comparison

Compare TUYA & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tuya Inc. each representing one

TUYA

Tuya Inc. each representing one

N/A

Current Price

$1.87

Market Cap

1.1B

Sector

Technology

ML Signal

N/A

Logo Solid Biosciences Inc.

SLDB

Solid Biosciences Inc.

N/A

Current Price

$10.27

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TUYA
SLDB
Founded
2014
2013
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
TUYA
SLDB
Price
$1.87
$10.27
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
11
Target Price
$3.49
$16.36
AVG Volume (30 Days)
544.3K
816.0K
Earning Date
05-11-2026
05-12-2026
Dividend Yield
5.40%
N/A
EPS Growth
N/A
34.97
EPS
N/A
N/A
Revenue
N/A
$8,094,000.00
Revenue This Year
$13.76
N/A
Revenue Next Year
$11.90
N/A
P/E Ratio
$27.45
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.61
$3.79
52 Week High
$2.73
$11.45

Technical Indicators

Market Signals
Indicator
TUYA
SLDB
Relative Strength Index (RSI) 59.65 62.71
Support Level $1.87 $5.21
Resistance Level $1.97 $11.45
Average True Range (ATR) 0.06 0.43
MACD 0.01 0.09
Stochastic Oscillator 76.35 90.46

Price Performance

Historical Comparison
TUYA
SLDB

About TUYA Tuya Inc. each representing one

Tuya Inc is an AI cloud platform service provider dedicated to bringing AI into everyday life. The group leverages its TuyaOpen open-source framework and universal AI Agent engines, including the AI Agent development platform, to integrate multimodal AI capabilities and reduce barriers to AI development. It drives the adoption of AI-powered lifestyles and speeds up the integration of AI with the physical world. It offers physical AI solutions for smart devices, commercial use, and industry developers using cloud computing and spatial intelligence. It builds a developer community that collaborates to create smart solutions grounded in sustainability, security, efficiency, agility, and openness. All the Group's revenue are derived from within the PRC.

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases. The majority of its current programs are designed to treat these diseases with gene transfer products. The company operates in a single segment, developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases.

Share on Social Networks: